Skip to main content
Log in

X-ray repair cross-complementing group 1 (XRCC1) Arg 399 Gln polymorphism and aflatoxin B1 (AFB1)-related hepatocellular carcinoma (HCC) in Guangxi population

  • Articles
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective: To explore the relationship of XRCC1 Arg 399 Gln polymorphism and AFB1-related hepatocellular carcinoma (HCC) risk in Guangxi population. Methods: The DNA samples from peripheral blood white blood cells were obtained from subjects including 140 HCC and 536 controls. The XRCC1 gene 399 codon polymorphism was detected by PCR-RFLP technique. Results: The frequency of XRCC1 399 Arg/Gln & Gln/Gln genotype in HCC patients (48.57%) was significantly higher that in normal controls (32.46%), and XRCC1 399 Arg/Gln & Gln/Gln genotype was associated with increased risk of HCC (adjusted odds ratios (OR)=2.18, 95% confidence interval (CI) 1.27∼3.74). In addition, in the cohort of low/median level of AFB1 exposure, the codon 399 Gln allele was associated with a conspicuous significantly increasing risk for HCC (adjusted OR=2.06, 95% CI=1.01∼4.20). Conclusion: The results indicate that the XRCC1 399 Gln allele is a potentially important determinant of susceptibility to AFB1-related HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wang JS, Huang T, Su J, et al. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People’s Republic of China [J]. Cancer Epidemiol Biomarkers Prev 2001; 10:143–6.

    PubMed  CAS  Google Scholar 

  2. Jan HJ, Hoeijmakers. Genome maintence mechanisms for preventing cancer [J]. Nature 2001; 411:366–74.

    Article  Google Scholar 

  3. Lunn RM, Langlois RG, Hsieh LL, et al. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency [J]. Cancer Res 1999; 59:2557–61.

    PubMed  CAS  Google Scholar 

  4. Wang Y, Spitz MR, Zhu Y, et al. From genotype to phenotype: correlating XRCC1 polymorphism with mutagen sensitivity [J]. DNA Repair 2003; 2:901–8.

    Article  PubMed  CAS  Google Scholar 

  5. Case C, Hu YC, Ahrendt SA, et al. The XRCC1 codon 399 Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer [J]. Mutat Res 2003; 528:19–27.

    Google Scholar 

  6. Li Y, Marion ML, Rundle A, et al. A common polymorphism in XRCC1 as a biomarker if susceptibility for chemically induced genetic damage [J]. Biomarkers 2003; 8:408–14.

    Article  PubMed  CAS  Google Scholar 

  7. Park JY, Lee SY, Jeon HS, et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer [J]. Cancer Epideniol Biomarkers Prev 2002; 11:23–7.

    CAS  Google Scholar 

  8. Rybicki BA, Conti DV, Moreira A, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer [J]. Cancer Epidermiol Biomarkers Prev 2004; 13:23–9.

    Article  CAS  Google Scholar 

  9. Divine KK, Gilliland FD, Crowell RE, et al. The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung [J]. Mutat Res 2001; 461:273–8.

    PubMed  CAS  Google Scholar 

  10. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. Inheritance of the 194 Trp and the 399 Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt [J]. Cancer Lett 2000; 159:79–86.

    Article  PubMed  CAS  Google Scholar 

  11. Shu XC, Cai Q, Gao YT, et al. A population-based case-control study of the Arg 399 Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer [J]. Cancer Epidermiol Biomarkers Prev 2003; 12:1462–7.

    CAS  Google Scholar 

  12. Yu HP, Zhang XY, Wang XL, et al. DNA repair gene XRCC1 polymorphism, smoking, and esophageal cancer risk [J]. Cancer Detect Prev 2004; 28:194–9.

    Article  PubMed  CAS  Google Scholar 

  13. Duell EJ, Holly EA, Bracci PM, et al. A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma [J]. Cancer Res 2002; 62:4630–6.

    PubMed  CAS  Google Scholar 

  14. Vidal AE, Boiteux S, Hickson ID, et al. XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions [J]. EMBO J 2001; 20:6530–9.

    Article  PubMed  CAS  Google Scholar 

  15. Yu MW, Yang SY, Pan IJ, et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma [J]. J Natl Cancer Inst 2003; 95:1485–8.

    PubMed  CAS  Google Scholar 

  16. Wang JS, Groopman JD, DNA damage by mycotoxins [J]. DNA damage by mycotoxins. Mutat Res 1999; 424:167–81.

    PubMed  CAS  Google Scholar 

  17. Memisoglu A, Samson L. Base excision repair in yeast and mammals[J]. Mutat Res 2000; 451:39–51.

    PubMed  CAS  Google Scholar 

  18. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded [J]. Mutat Res 2000; 459:1–18.

    PubMed  CAS  Google Scholar 

  19. Shen HM, Ong CN. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis [J]. Mutat Res 1996; 366:23–44.

    PubMed  Google Scholar 

  20. Hsieh LL, Chien HT, Chen IH, et al. The XRCC1 399 Gln polymorphism and frequency of p53 mutations in Taiwanese Oral squamous cell carcinomas [J]. Cancer Epidermiol Biomarkers Prev 2003; 12:439–43.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ma Yun.

Additional information

Foundation item: This work was supported by the National Natural Science Foundation of China (No. 39860032).

Biography: LONG Xi-dai (1973–), male, master of medicine, Guangxi Medical University, majors in tumor pathology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Long, Xd., Ma, Y., Wei, Yp. et al. X-ray repair cross-complementing group 1 (XRCC1) Arg 399 Gln polymorphism and aflatoxin B1 (AFB1)-related hepatocellular carcinoma (HCC) in Guangxi population. Chin. J. Cancer Res. 17, 17–21 (2005). https://doi.org/10.1007/s11670-005-0004-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-005-0004-7

Key words

CLC number

Navigation